The Shandong Province DrugSafety Public Opinion Case Evaluation Conference was held

Recently, the Shandong Province Drug Safety Public Opinion Case Evaluation Conference was held in Jinan. The conference focused on the analysis and discussion of typical public opinion cases of drug safety, and carried out emergency drills in the form of desktop deduction, aiming to improve the public opinion management and public opinion guidance ability of the drug supervision system in Shandong Province. Zhang Wei, President of the China Drug Administration Research Association, relevant responsible persons of China Health Media Group delivered speeches at the meeting, and Li Tao, Secretary of the Party Group and Director of the Shandong Provincial Food and Drug Administration, attended and spoke at the meeting. Relevant responsible persons of the Food and Drug Administration of Tianjin, Zhejiang, Anhui, Henan, Sichuan and other provinces (cities) attended the meeting.

This conference is the first public opinion case analysis activity carried out by provincial drug regulatory authorities in China, and is organized by China Health Media Group entrusted by the Shandong Provincial Food and Drug Administration. The conference was divided into two topics: case studies and emergency drills. Experts from the China Drug Regulatory Research Association, the Cyberspace Administration of Shandong Provincial Party Committee, Communication University of China, Fudan University, Shandong University, China Health Media Group and other units made all-round comments from the aspects of public opinion risk early warning, public opinion analysis and judgment, and public opinion response guidance. The emergency drill of drug safety incidents adopts the form of desktop deduction, simulates the whole process of the occurrence, development and end of a drug safety incident, and runs through information reporting, incident investigation, hazard control, public opinion management, news release and other work, so as to improve emergency handling capabilities with practical exercises.

The meeting emphasized that it is necessary to tighten the ideological strings, continuously enhance political acumen, public opinion sensitivity and problem insight, and predict trend risks and emerging events in advance, make advance arrangements, and respond quickly. It is necessary to tighten the chain of responsibility, carry out offline investigation and disposal as soon as possible, fundamentally solve the practical problems reflected by public opinion, and do a good job in public opinion management and emergency response according to duties. It is necessary to fight the active battle, base on the fast, move the threshold forward, grasp the time and efficiency, make every effort to prevent and resolve the risk of public opinion on drug safety, and continuously improve public opinion and emergency management capabilities.

As the specific organizer of this conference, China Health Media Group continues to make deep efforts in public opinion work. The review of public opinion case analysis is an important part of the whole life cycle of public opinion work, which has very important reference value and reference significance for understanding the law of drug public opinion communication, grasping the characteristics of drug public opinion, mastering public opinion response skills, learning lessons and lessons, and guiding future work. The public opinion case analysis activity also provides a communication platform for regulatory departments, experts and scholars at all levels, and promotes the exchange of experience and experience in public opinion guidance work.

At present, the Public Opinion Monitoring Center of China Health Media Group discovers, perceives and predicts risks through advanced technology means, upgrades the public opinion monitoring system, tempers the public opinion analysis team, and creates a public opinion expert think tank, which has formed a benign working mechanism and public opinion solution of "five-in-one" monitoring, identification, early warning, research and judgment, and prevention. Provide full-process and full-chain services in terms of pre-event monitoring and early warning, in-process analysis and judgment, post-event summary and review, and daily capacity improvement, so as to provide technical support for creating a good public opinion atmosphere for drug safety. In the future, China Health Media Group will continue to give full play to the professional advantages of media, the strong support of technology, and the role of think tanks as think tanks, and assist regulatory departments at all levels to do a good job in news publicity, public opinion guidance and smart supervision.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.

Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.

HOT

NEW